TP53 and cancer: 1. Distinct mutational signatures were identified in the whole exomes of HCC patients with aristolochic acid exposure.2. The aristolochic acid signature also revealed known cancer driver genes, TP53 and CTNNB1, mutated 54 and 24 percent of the total HCC cases respectively.